Tag: BMY
Bristol Myers Squibb (BMY) earnings Q1 2024
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glan [...]
Bristol Myers Squibb (BMY) Q4 earnings report 2023
Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales grow [...]
Bristol Myers Squibb (BMY) Q3 earnings report 2023
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sale [...]
BMY stock slips as forex impact triggers 2022 guidance cut (NYSE:BMY)
Drew Angerer/Getty Images News Bristol Myers Squibb (NYSE:BMY) has lost ~1% in the pre-market despite better than expected financials for 2Q 2022 [...]
Bristol-Myers’ (BMY) Q2 Earnings Beat, Opdivo Gross sales Develop
Bristol-Myers Squib [...]
Notable ETF Outflow Detected – XLV, PFE, ABBV, BMY
Looking at this time at week-ov [...]
ITOT, JNJ, PFE, BMY: Giant Outflows Detected at ETF
Looking immediately at week-ove [...]
Bristol Myers Squibb (BMY) Positive aspects However Lags Market: What You Ought to Know
Bristol Myers Squibb (BMY) closed the newest buying [...]
Bristol Myers (BMY) is an Unimaginable Development Inventory: three Causes Why
Development buyers concentrate on shares which are seeing above-average monetary development, as this characteristic helps these securities garner [...]
Bristol Myers (BMY) Will get FDA Approval for CAR T-Cell Remedy
Bristol Myers Squibb BMY introduced that the FDA has authorized its CD19-directed chimeric antigen receptor (CAR) T cell remedy, Breyanzi (lisocabt [...]